|
|
||||||||




,
,




Malaria Department, Biomedical Research Institute, Rockville, Maryland
Department of Immunology, Division of Communicable Diseases and Immunology, Walter Reed Army Institute of Research, Washington, DC
Malaria Branch, Infectious Diseases Department, Naval Medical Research Institute, Bethesda, Maryland
Molecular Genetics, Smith, Kline and French Laboratories, Swedeland, Pennsylvania
INTRODUCTION* Recombinant and synthetic peptide technology has allowed new approaches to the study of parasitic diseases. A major benefit of these advances is the ease with which entire genes can be isolated and sequenced at the nucleotide level. This information can help answer questions on genomic organization and evolution. Moreover, we can deduce the entire amino acid sequence of a particular protein without having sufficient protein to visualize on an acrylamide gel. The challenge of translating the nucleotide sequence into a biologically relevant and functional protein remains.
We intend to focus attention on a particular way to accomplish that translation, i.e., the use of polypeptides derived from the deduced sequence to probe or model a function or property of the protein. It is often easier to obtain large amounts of relatively pure recombinant or synthetic polypeptides than of the original protein. Caveats about the use of such peptides cannot be overstated.
* A symposium to consider recombinant and synthetic peptide technology in the study of the malarias was held on 8 December 1986 at the 35th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Chairpersons were S. B. Aley and G. H. Campbell.
This article has been cited by other articles:
![]() |
G. Lowell, W. Ballou, L. Smith, R. Wirtz, W. Zollinger, and W. Hockmeyer Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides Science, May 6, 1988; 240(4853): 800 - 802. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |